Crizotinib acetate
Crizotinib is an orally administered small molecule inhibitor targeting the c-Met/HGFR tyrosine kinase, exhibiting potential antineoplastic properties. It is widely used in cancer research, particularly in studies involving ALK and ROS1-driven tumors, with applications in both in vitro cellular assays and in vivo xenograft models.
Product Specifications
CAS Number
877399-53-6
Field of Research
Cardiovascular Research, Pharmacology & Drug Discovery, Signal Transduction
Smiles
C (C) (O) =O.O ([C@H] (C) C1=C (Cl) C (F) =CC=C1Cl) C2=CC (C3=CN (N=C3) C4CCNCC4) =CN=C2N
Molecular Formula
C23H26Cl2FN5O3
Molecular Weight
510.39
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
